BCL2 and cancer: MiR-15a/16-1 cluster within 0.5 kb at chromosome position 13q14 target several oncogenes (including BCL2, CCNE1 and CCNB1, which also existed in the two networks), to suppress cell cycle progression and proliferation in several malignant tumors [35–37].